Written statement of proposed testimony – Eric Wang. CEO, Ecofibre. 7/28/22 Madame Chairwoman, members of the committee, I am very grateful for the opportunity to testify to you today about the emerging U.S. hemp industry, its challenges, and its many opportunities that can be achieved through your assistance with the 2023 U.S. Farm Bill. I […]
Media Release. Ananda Professional Conducts Novel Research Study for Patients with Pelvic Pain Media Release – FREE HER Ananda Professional is pleased to announce a novel research study for women with pelvic pain conditions including endometriosis, dysmenorrhea and vulvodynia. This Institutional Review Board (IRB)-approved study is called FREE HER (Finding Relief from Endometriosis and Exclusion: […]
Hemp Gazette wrote an article covering Ananda Hemp’s clinical trail. “… the race is on to be the first to market to tap into the pent-up demand in Australia for OTC CBD. Targeting restless sleepers, Southern Cross University researchers have commenced a Phase IIb double blind, randomised, placebo-controlled, multi-site clinical trial funded Australia’s Ecofibre. Ecofibre […]
Ecofibre’s Chief Scientist Alex Capano was featured as part of a story into the state of advertising in the CBD market.
In this article, The Inquirer reports on the university’s investment in Ecofibre as a strategic partner, gaining the university an extra $1.1m worth of value from the surge in share price in the days after Ecofibre’s IPO.
In this article, The Australian Financial Review report on the 70% surge in the Ecofibre share price on day 1 of trading – the day of its official IPO.
This article offers an inside view to the thoughts of 10 leaders in the cannabis industry. Article title: “10 Cannabis Leaders – And the People Who Inspire Them”.
Marie Claire Article: “An Expert Answers All Your Questions About CBD”.
CBD MD Article: “Is CBD the Anti-Inflammatory of the Future?”